>>18198203 (pb)
>Back in 2011, O'Day was on President Trump's reality competition show, The Apprentice. She later claimed that she had an affair with his son, who was married at the time."
Any relation?
Gilead Sciences CEO Daniel O’Day says 50,000+ courses of its experimental #Covid19 therapy Remdesivir are ready to ship.
Dr. Anthony Fauci @NIAIDNews
said early results of @GileadSciences
' clinical trial offered “quite good news.”
2020-04-30
https://twitter.com/Quicktake/status/1255738686249013251
THE PRESIDENT: I’m pleased to announce that Gilead now has an EUA from the FDA for remdesivir. And you know what that is because that’s been the hot thing also in the papers and in the media for the last little while. An important treatment for hospitalized coronavirus patients. And it’s something — I spoke with Dr. Hahn and Dr. Fauci; I spoke with Deborah about it. And it’s — it’s really a very promising situation.
We’ve been doing work with the teams at the FDA, NIH, and Gilead for spearheading this public-private partnership to make this happen very quickly.
MR. O’DAY: And, in fact, really, the thanks go to the patients and the caregivers that participated in these clinical trials.
MR. O’DAY: Well, I think we’re still — it’s early days on coronavirus. I think this is the first step today. And I think what we’ll see — and it may be like with other viruses that we’ve seen: that with this base step, with an antiviral like remdesivir, that the way to actually even get better results is to add medicines on top of an antiviral. That has been — that was really how we were able to get HIV to a chronic illness: by a combination of therapies.
THE PRESIDENT: That’s very exciting.
2020-05-01
https://trumpwhitehouse.archives.gov/briefings-statements/remarks-president-trump-announcement-remdesivir/
Follow the money: Big Pharma, Dr. Fauci and the death of hydroxychloroquine
Dr. Fauci and his cohorts did everything possible to promote remdesivir and downplay HCQ, possibly costing millions of lives around the globe.
It was an interesting change because a leaked World Health Organization study of remdesivir showed there was no statistically significant clinical benefits in using the drug on COVID-19 patients and that it had severe side effects. However, it did show some promise in reducing recovery time. When the news broke of this study to the public, on April 23, Gilead shares fell.
On May 1, the NIH’s COVID-19 Treatment Guidelines panel members granted emergency use of remdesivir and stated HCQ could only be used in hospitals or in studies. Investigative journalist Sharyl Attkisson found 11 members of that panel had financial ties to Gilead.
https://www.washingtontimes.com/news/2021/jun/9/follow-the-money-big-pharma-dr-fauci-and-the-death/
Remdesivir shouldn't be used on hospitalized Covid-19 patients, WHO advises
Remdesivir has no meaningful effect on mortality or reducing the need for mechanical ventilation, an expert panel said.
2020-11-20
https://www.nbcnews.com/health/health-news/remdesivir-shouldn-t-be-used-hospitalized-covid-19-patients-who-n1248320
Truvada and a related drug, Descovy, have been blockbusters for Gilead, earning the company over $[3.3] billion in combined sales last year.
https://www.reuters.com/legal/litigation/ruling-gives-gilead-boost-billion-dollar-hiv-drug-patent-fight-2022-12-01/
Gilead Sciences, Inc. [333] Lakeside Drive
https://www.drugs.com/manufacturer/gilead-sciences-inc-61.html